Sodium oxybate: Updates and correction to previously published safety data

Journal of Clinical Sleep Medicine

Volumn 7, Issue 4, 2011, Pages 415-416

  Wang, Y Grace ^a   Swick, Todd J ^b   Carter, Lawrence P ^c   Thorpy, Michael J ^d,e   Benowitz, Neal L ^f  

^a JAZZ PHARMACEUTICALS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYBATE SODIUM;

ACCIDENTAL DEATH; AUTOIMMUNE DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLOSTRIDIUM DIFFICILE INFECTION; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG FATALITY; DRUG MARKETING; DRUG OVERDOSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HUMAN; KIDNEY FAILURE; LETTER; MORTALITY; NEOPLASM; PHARMACY; POSTOPERATIVE COMPLICATION; PRESCRIPTION; SUICIDE; UROSEPSIS;

CAUSE OF DEATH; DRUG TOXICITY; HUMANS; PHARMACOVIGILANCE; SODIUM OXYBATE; SURVIVAL RATE; UNITED STATES;

EID: 80051872477     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/JCSM.1214     Document Type: Letter

References (0)